Premium
Pharmacodynamic effect of clopidogrel therapy and switching to cilostazol in patients with the CYP2C19 loss‐of‐function allele (ACCEL‐SWITCH) study
Author(s) -
JEONG Y.H.,
PARK Y.,
MUSE W. C.,
KWON T. J.,
KOH J.S.,
HWANG S.J.,
KWAK C. H.,
HWANG J.Y.
Publication year - 2012
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2012.04788.x
Subject(s) - cilostazol , cyp2c19 , clopidogrel , pharmacodynamics , medicine , pharmacology , aspirin , pharmacokinetics , cytochrome p450 , metabolism